Last updated on July 2019

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Brief description of study

The primary purpose of this study to continue follow-up of participants enrolled in the study E7080-M081-504 (NCT03663114) of lenvima capsules and to evaluate the overall survival of participants with hepatocellular carcinoma.

Clinical Study Identifier: NCT04008082

Find a site near you

Start Over

Eisai Trial Site #1

Osaka, Japan
  Connect »